1
Osclerotic plaque volume in the superficial femoral artery when compared to those already treated with statin given ezetimibe. Reverse vessel wall remodeling was noted among PAD patients newly treated with statins compared to those with ezetimibe added to preexisting statin therapy. Thus the degree and/or mechanism of LDL lowering rather than the final LDL achieved may be important in halting athe
1
Chemic injury. Overall, patients with DE had scores ranging from 1 to 19, with a mean of 5.4 (standard deviation = 4.8). Non-ischemic DE was most commonly seen in the anterolateral and inferior walls (Figure 3). There was no significant association between the presence of DE and time since transplant or current biopsy result. Conclusion: DE is a common feature in the transplant population. Most DE
1
Chemic injury. Overall, patients with DE had scores ranging from 1 to 19, with a mean of 5.4 (standard deviation = 4.8). Non-ischemic DE was most commonly seen in the anterolateral and inferior walls (Figure 3). There was no significant association between the presence of DE and time since transplant or current biopsy result. Conclusion: DE is a common feature in the transplant population. Most DE
1
Ent in 119 patients (82 ). There was no significant association with the extent of myocardial scarring and the occurrence of NSVTs, couplets, and PVCs (overall p = 0.05). However the extent of BZ was significantly associated with the occurrence of NSVTs, couplets and PVCs (overall p
1
Approach. Methods: Between January 2005 and October 2008 81 consecutive patients, showing a left ventricular dysfunction with apical ballooning not explainable by the coronary artery status and initially admitted with ACS underwent CMR using a 1.5 T MRI scanner. Left ventricular function, T2-weighted spin echo sequence for oedema and delayed enhancement (DE) images after administration of Gadobutr

Social Bookmarking Sites
What is Kliqqi?

Kliqqi is an open source content management system that lets you easily create your own user-powered website.

Latest Comments